Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Relapsed/Refractory Follicular Lymphoma
Clinical trial register · Poland

Relapsed/Refractory Follicular Lymphoma Trials in Poland, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2721 matching records held by the registry are in this view. Synced 19 Nov 2026, 03:18 UTC
2721
Studies in scope
all four open statuses
1385
Recruiting now
open to new participants
507
Lead sponsors
across recruiting studies
Top sites
Krakow 3 Bydgoszcz 2 Wroclaw 2 Gdansk 2 Poznan 2
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Relapsed/Refractory Follicular Lymphoma trials in Poland

3 of 2721 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Regeneron Pharmaceuticals
Phase 3
580
Bydgoszcz, Wałbrzych, Wroclaw, Lublin, Krakow, Gdansk, Poznan, Skorzewo
2023-12-28
Active, closed
BeOne Medicines
Phase 3
799
Bydgoszcz, Gdansk, Katowice, Krakow, Poznan, Torun, Warsaw
2022-03-10
Active, closed
Epizyme, Inc.
Phase 3
599
Skórzewo, Warsaw, Katowice, Krakow, Torun, Wroclaw
2020-06-11
Rows per page Showing 1–3 of 3
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 November 2026. https://priyalifescience.com/clinical-trials-poland/condition/relapsed-refractory-follicular-lymphoma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,721 studies in total at the last sync on 19 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3 of those studies listing the condition Relapsed/Refractory Follicular Lymphoma.

How many Relapsed/Refractory Follicular Lymphoma trials are recruiting in Poland?

1 of the 3 studies on this page are recruiting new participants as of the 19 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Relapsed/Refractory Follicular Lymphoma), 3 studies
PhaseStudiesRecruitingShare
Phase 331100%

Most active sponsors

Lead sponsors with the most studies (Relapsed/Refractory Follicular Lymphoma)
Lead sponsorStudiesRecruiting
BeOne Medicines10
Epizyme, Inc.10
Regeneron Pharmaceuticals11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.